Lung Therapeutics Acquired by Aileron Therapeutics | Read More

Advancing First-in-Class Therapies for Underserved Fibrosis and Lung Diseases

At Lung Therapeutics, we have a highly promising product pipeline that features two leading programs: LTI-01 and LTI-03. Our goal is to provide better treatment options for patients with life-threatening fibrosis and lung conditions.